Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic
- Quintela-Fandino
- M Colomer
- R
Drugs Of The Future (p. 81-89) - 1/1/2013
10.1358/dof.2013.38.2.1918242 Ver en origen
- ISSN 03778282
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy
- Quintela-Fandino, Miguel
- Hitt, Ricardo
- Medina, Pedro P.
- Gamarra, Soledad
- Manso, Luis
- Cortes-Funes, Hernan
- Sanchez-Cespedes, Montserrat;
Journal Of Clinical Oncology (p. 4333-4339) - 10/9/2006
10.1200/jco.2006.05.8768 Ver en origen
- ISSN 0732183X
Critically short telomeres and toxicity of chemotherapy in early breast cancer
- Quintela-Fandino M
- Soberon N
- Lluch A
- Manso L
- Calvo I
- Cortes J
- Moreno-Antón F
- Gil-Gil M
- Martinez-Jánez N
- Gonzalez-Martin A
- Adrover E
- de Andres R
- Viñas G
- Llombart-Cussac A
- Alba E
- Mouron S
- Guerra J
- Bermejo B
- Zamora E
- García-Saenz JA
- Simon SP
- Carrasco E
- Escudero MJ
- Campo R
- Colomer R
- Blasco MA
Oncotarget (p. 21472-21482) - 1/1/2017
- ISSN 19492553
- iMarina
Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice
- Moreno-Lama L
- Galindo-Campos MA
- Martínez C
- Comerma L
- Vazquez I
- Vernet-Tomas M
- Ampurdanés C
- Lutfi N
- Martin-Caballero J
- Dantzer F
- Quintela-Fandino M
- Ali SO
- Jimeno J
- Yélamos J
Oncogene (p. 2835-2843) - 26/3/2020
10.1038/s41388-020-1175-x Ver en origen
- ISSN 09509232
Colorectal hepatic metastases: Intraarterial chemotherapy
- Grávalos Castro C
- Murillo González T
- Quintela-Fandino M
Revisiones En Cancer (p. 226-238) - 3/12/2004
- ISSN 02138573
- iMarina
Coexistence of two rare sarcomas: Primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver
- Gonzalez-Billalabeitia E
- Quintela-Fandino M
- Alemany I
- López-Alonso G
- Ruiz-Ollero A
- Martinez-Tello F
- Hitt R
Sarcoma - 23/5/2008
10.1155/2008/416085 Ver en origen
- ISSN 13691643
CX3CL1 promotes breast cancer via transactivation of the EGF pathway
- Tardáguila M, Mira E, García-Cabezas MA, Feijoo AM, Quintela-Fandino M, Azcoitia I, Lira SA, Mañes S
Cancer Research (p. 4461-4473) - 15/7/2013
- ISSN 00085472
- iMarina
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support
- Quintela-Fandino, Miguel
- Lopez, Joaquin Martinez
- Hitt, Ricardo
- Gamarra, Soledad
- Jimeno, Antonio
- Ayala, Rosa
- Hornedo, Javier
- Guzman, Cecilia
- Gilsanz, Florinda
- Cortes-Funes, Hernan
Journal Of Clinical Oncology (p. 3611-3618) - 1/8/2006
10.1200/jco.2005.04.0576 Ver en origen
- ISSN 0732183X
Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors
- Bueno M
- Sanchez J
- Colomer R
- Quintela-Fandino M
Current Drug Targets (p. 1735-1746) - 1/1/2016
10.2174/1389450117666160502151857 Ver en origen
- ISSN 13894501
- iMarina
- iMarina
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
- Lord, Simon
- Funes, Juan M.
- Harris, Adrian L.
- Quintela-Fandino, Miguel;
Current Drug Targets (p. 1714-1727) - 1/1/2016
10.2174/1389450117666160307143718 Ver en origen
- ISSN 13894501
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id